| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income (loss) | 10,028 | 6,299 | -9,354 | -97,007 |
| Accrued compensation | - | - | - | -161 |
| Provision for credit loss | 548 | 262 | - | 123 |
| Loss on right of use assets | 0 | 0 | 0 | -135 |
| Gain on sale of property and equipment | 72 | 72 | - | 8 |
| Depreciation and amortization | 22,648 | 14,663 | 7,627 | 20,254 |
| Amortization-investment discount | 1,041 | 731 | 370 | 2,084 |
| Amortization-debt issuance costs | 1,321 | 881 | 440 | 978 |
| Equity-based compensation | 48,967 | 32,740 | 17,187 | 54,896 |
| Non-cash lease expense | 1,178 | 246 | 395 | 1,360 |
| Accounts receivable | 66,451 | 129,259 | 60,155 | 19,226 |
| Prepaid expenses and other current assets | 84,326 | 56,333 | 43,800 | 8,809 |
| Other assets | 47 | 52 | 23 | -77 |
| Medical expenses payable | 239,008 | 165,366 | 106,946 | 91,726 |
| Accounts payable and accrued expenses | 11,180 | 8,554 | 5,208 | 2,835 |
| Deferred premium revenue | 5 | 77 | 157 | -116 |
| Accrued compensation | 8,349 | 3,085 | -7,577 | - |
| Lease liabilities | -993 | 20 | -65 | -1,492 |
| Net cash provided by operating activities | 190,302 | 45,746 | 16,616 | 43,481 |
| Purchase of investments | 45,194 | 35,001 | 17,905 | 75,524 |
| Sale of property and equipment | 75 | 75 | - | 14 |
| Maturities of investments | 57,995 | 39,990 | 22,695 | 152,755 |
| Sale of business | 1,065 | 1,065 | - | - |
| Acquisition of property and equipment | 21,752 | 16,255 | 8,252 | 32,134 |
| Net cash (used in) provided by investing activities | -7,811 | -10,126 | -3,462 | 45,111 |
| Proceeds from long-term debt | 0 | 0 | - | 50,000 |
| Payment of employment taxes related to release of restricted stock | 0 | 0 | 0 | 350 |
| Debt issuance costs | 26 | 26 | 26 | 512 |
| Proceeds from stock option exercises | 2,771 | 1,823 | 207 | - |
| Contributions from noncontrolling interest holders | 0 | 0 | 0 | 15 |
| Net cash provided by financing activities | 2,745 | 1,797 | 181 | 49,153 |
| Net increase in cash | 185,236 | 37,417 | 13,335 | 137,745 |
| Cash and cash equivalents at beginning of period | 434,942 | - | - | - |
| Cash and cash equivalents at end of period | 620,178 | - | - | - |
Alignment Healthcare, Inc. (ALHC)
Alignment Healthcare, Inc. (ALHC)